NCT03640195View on ClinicalTrials.gov

Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

December 4, 2017

Study Completion Date

December 4, 2017

Conditions
Head and Neck Cancer
Interventions
OTHER

Device: Transcutaneous acupoint electrical stimulation and seeds for auricular acupressure

"Experimental group received Acupoint stimulation, Transcutaneous acupoint electrical stimulation20 minutes/weeks, once a week for six consecutive weeks.~The second part of The Experimental group received Auricular acupressure applied to four acupoints, including shenmen (TF2), mouth (IC6), subcortex (CW2), Occiput (AT3). each point is 1min, 5days/week, 3 times/day."

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03640195 - Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy | Biotech Hunter | Biotech Hunter